Affiliation:
1. Faculty of Dentistry, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
2. Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
3. Department of Endocrinology, National Institute of Endocrinology C. I. Parhon, 011853 Bucharest, Romania
Abstract
Objective. This study examined the potential use of computed tomography panoramic mandibular indices on cone beam CT (CBCT) for assessing bone density in postmenopausal women with low bone mass. Study design. The study enrolled 104 postmenopausal women who underwent dual-energy X-ray absorptiometry (DXA) using a DXA scanner and mental foramen region CBCT alongside the NewTom VGi EVO Cone Beam 3D system. We assessed the relationship between the following DXA parameters: lumbar, femoral neck, and total hip T score, bone mineral density (BMD), and lumbar trabecular bone score (TBS). The following panoramic mandibular indices were also considered: the computed tomography mandibular index superior (CTI(S)), computed tomography mandibular index inferior (CTI(I)), and computed tomography mental index (CTMI). Results. The study revealed moderate correlations between CBCT indices and BMD/TBS scores: CTMI showed the highest correlation with the femoral neck T-score (r = 0.551, p < 0.0001). TBS scores were also moderately correlated with CBCT indices: CTMI showed a moderate positive correlation with TBS (r = 0.431, p < 0.0001); CTI(S) had a similar moderate positive correlation with TBS (r = 0.421, p < 0.0001). AUC values ranged from 0.697 to 0.733 for osteoporosis versus the osteopenia/normal group and from 0.734 to 0.744 for low versus normal bone quality groups, p < 0.0001. The comparison of the values of the studied indices between low versus normal bone quality (quantified with TBS) groups showed high sensitivity but low specificity. Conclusions. CBCT-measured indices CTI(S), CTI(I), and CTMI are useful in assessing patients with low bone mass to improve, by specific treatment, the prognosis of dental implants.
Funder
University of Medicine and Pharmacy Carol Davila through the institutional program Publish not Perish
Reference24 articles.
1. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis;Schini;J. Endocrinol. Investig.,2024
2. Adejuyigbe, B., Kallini, J., Chiou, D., and Kallini, J.R. (2023). Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics. Int. J. Mol. Sci., 24.
3. Postmenopausal Osteoporosis: A Literature Review;Bhatnagar;Cureus,2022
4. On the Prevention WHOSG of Osteoporosis (2003). Prevention and Management of Osteoporosis: Report of a WHO Scientific Group, World Health Organization.
5. American association of clinical endocrinologists and american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2016;Camacho;Endocr. Pract.,2016